MOUNT LAUREL, N.J., May 9 /PRNewswire/ -- ImpactRx, Inc., the only company measuring the direct impact of promotion on patient treatment as it occurs, today announced that current Chief Executive Officer and President Nancy Lurker will be leaving the company to assume a new leadership position within the pharmaceutical industry. Current Chief Financial Officer Richard Altus will replace Ms. Lurker as president and acting CEO of the company.
Since joining ImpactRx as CEO and President in 2003, Ms. Lurker has spearheaded the growth of the company into new markets in the industry and has overseen the launch of new product services, including ONCLink(TM), ManagedMarketsLink(TM), SampleLink(TM), MessageLink(TM) and ImpactOnline(TM).
Per Lofberg, President of Merck Capital Ventures, and investor in ImpactRx and Chairman of its Board of Directors thanked Ms. Lurker for her vital contributions to the growth and development of the company during her term as CEO and president.
“Our company has seen great advancement under Nancy’s leadership and direction over the past two and a half years,” said Lofberg. “Under her guidance, ImpactRx has grown from a small start-up company to a major player in the pharmaceutical promotion measurement industry. We look forward to continued growth and expansion as we continue to provide innovative pharmaceutical promotion data to the industry.”
Mr. Altus will assume the role of President and acting CEO effective immediately. Possessing over 25 years of financial and management experience, Mr. Altus has served as ImpactRx’s Chief Financial Officer since 2002, where he has overseen the company’s major financial ventures. Before joining ImpactRx, Mr. Altus served a number of top executive roles for several private and public companies; most recently Mr. Altus served as the Chief Operating Officer for Medical Broadcasting Company, a company that pioneered the use of online and e-strategy marketing techniques for the pharmaceutical and biotechnology industry.
“Over the past four years, I have seen ImpactRx significantly expand its services within the pharmaceutical industry,” said Altus. “I am looking forward to helping our clients achieve even greater insights and solutions to their critical business problems by leveraging the phenomenal talent we have here at ImpactRx.”
“Rich’s significant financial and management experience, both at ImpactRx and his previous positions throughout his career, will serve him well in this new role. For the past 18 months Rich has expanded on his duties at ImpactRx by taking on day-to-day operational management responsibilities for the company. I am confident that his leadership and experience will benefit the company as we continue to expand our presence as a leading provider of promotion measurement data to the pharmaceutical industry,” said Lofberg.
About ImpactRx
Founded in October 2000, ImpactRx’s physician network is the source of unprecedented intelligence capability for assessing the impact of key pharmaceutical sales force and brand drivers on physician behavior and brand performance. Based in Mount Laurel, New Jersey, ImpactRx is a privately held company.
CONTACT: Patrick Angelastro SVP, Strategic Development Phone: (856) 273-0221 E-mail: pangelastro@impactrx.com
ImpactRx, Inc.
CONTACT: Patrick Angelastro, SVP, Strategic Development, of ImpactRx,Inc., +1-856-273-0221, or pangelastro@impactrx.com
